"With nearly 40% of all new FDA approvals over the last two years coming from companies with a footprint in NJ, our state continues to lead the way in bringing new therapies and cures to patients."
"ESG is ethically and financially necessary for companies in the current environment, so we wanted to help them navigate the complexities of reporting."
"One of our major value propositions entails “disruption by elimination” by developing mine hardened multi-variable measurement and devices that eliminate complex PLCs, cabinets, engineering services and wiring."
"MassBio remains focused on providing the necessary support to help companies succeed so we can continue to stay the best place in the world for life sciences."
"The main trait we are looking for in partners is access to interesting chemical libraries where, combining good chemistry with our platforms, we can identify novel treatments for neuropsychiatric disorders."
This pre-release, containing insights from executives across leading African upstream, downstream, financing, and service providers, spotlights developments in local capabilities, infrastructure, and new projects that are driving change in some of Africa's most interesting oil and gas producing countries.